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Abstract
Development of biocompatible antioxidant nanoparticles for xenobiotic-induced liver disease treat-
ment by oral or parenteral administration is of great interest in medicine. In the current study, we
demonstrate the protective effects of coenzyme Q10 nanoparticles (CoQ10-NPs) on hepatotoxic-
ity induced by dichlorvos (DDVP) as an organophosphate. Although CoQ10 is an efficient
antioxidant, its poor bioavailability has limited the applications of this useful agent. First, CoQ10-
NPs were prepared then characterized using dynamic light scattering (DLS) and transmission elec-
tron microscopy (TEM). In DDVP-treated and non-treated hepatocytes in the presence of CoQ10-
NPs, cell viability, the level of reactive oxygen species (ROS), lipid peroxidation (LPO), mitochon-
drial membrane potential (MMP), lysosome membrane integrity, and cellular glutathione (GSH)
content were measured. The prepared CoQ10-NPs were mono-dispersed and had narrow size dis-
tribution with average diameter of 54 nm. In the in vivo study, we evaluated the enzymes, which
are involved in the antioxidant system for maintenance of normal liver function. In comparison to
nonparticulate CoQ10, the CoQ10-NPs efficiently decreased the ROS formation, lipid peroxidation
and cell death. Also, particulate form of CoQ10 improved MMP, GSH level and lysosome mem-
brane integrity. In the in vivo, study, we revealed that CoQ10-NPs were better hepatoprotective
than its nonparticulate form (P < .05). Altogether, we propose that the CoQ10-NPs have potential
capability to be used as a therapeutic and prophylactic agent for poisoning that is induced by
organophosphate agents, especially in the case of DDVP. Furthermore, these positive remarks
make this nanoparticle amenable for the treatment of xenobiotic-induced liver diseases.
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1 | INTRODUCTION
The exposure to organophosphates such as dichlorvos (DDVP) results
in prominent neurotoxicity and hepatotoxicity.1,2 Liver, with crucial
importance in metabolism and detoxification of chemicals, seems to be
a potential site for organophosphates especially DDVP-induced dam-
ages;3,4 however, it has been recognized that chronic and sub-chronic
hepatotoxicity of organophosphates is closely linked to the oxidative
stress.5–7
DDVP is an organophosphate pesticide that effectively acts
against various types of agricultural, household, public health and fish
farming pests and works as plasticizers and flame retardants in indus-
try.8 Despite the regulations and/or limitations by the United States
Environmental Protection Agency (EPA), World Health Organization
(WHO) and Agency for Research on Cancer on human health risk,9 it is
still used over the world, particularly in developing countries, because
of its broad-spectrum actions. Previous studies have demonstrated that
in the mitochondria isolated from rat brain exposed to DDVP, GSH
level decreases and content of ROS significantly increases.1,10
It has been recognized that powerful antioxidants such as Coen-
zyme Q10 (CoQ10), which can directly scavenge ROS and indirectly
regenerate cellular vitamin E and C, are able to reduce the lipid
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peroxidation (LPO) in cellular membranes.11 CoQ10, also known as
ubiquinone, is a salient endogenous lipid-soluble and vitamin-like sub-
stance that acts as a proton–electron carrier in the mitochondrial elec-
tron transport chain and consequently supply energy need (ATP) of
cell.12,13 Furthermore, it has been presented that CoQ10 had hepato-
protective impacts against xenobiotic-associated cellular damage and
oxidative stress in several cases such as statins, acid salicylic acid, thioa-
cetamide, tetrachloride carbon and doxorubicin.14–16
In spite of having protective role against toxicities induced by
xenobiotics, CoQ10 represents significant lipid solubility and low bioa-
vailability that limit its clinical applications; therefore, higher doses are
needed to be administered orally for clinical applications.17 It is worth
noting that researches have achieved obvious therapeutic effectiveness
in humans only in the long term and high dose CoQ10 administration,
which forces researchers to seek strategies for overcoming these
limitations.18
In this study, we aimed to test and compare the hepatoprotective
and prophylactic effects of the nonparticulate CoQ10 on DDVP-
induced hepatotoxicity and oxidative stress in isolated rat liver cells. In
these cells, viability, ROS formation, lipid peroxidation, GSH level, and
mitochondrial/lysosomal function were studied and for complementary
investigations to confirm in vitro results we carried out in vivo assays
that could valuate the DDVP-induced liver damage and effects of
CoQ10 and CoQ10-NPs.
2 | METHODS AND MATERIALS
2.1 | Chemicals
Thiobarbituric acid (TBA), trypan blue, GSH, and phenobarbital were
prepared from Merck Chemical Company (Darmstadt, Germany). 4-2-
hydroxyethyl-1-piperazineethanesulfonic acid (HEPES were prepared
from Acros (New Jersey, USA). Other agents were obtained from
Sigma–Aldrich Chemical Company (St. Louis, MO).
2.2 | Synthesis of CoQ10-NPs
CoQ10 nanoparticles were produced by precipitation method.18 The
solvent for 10 mg of CoQ10 was ethanol (3.0 mL) which is the organic
phase of the solution. The obtained solution was poured into 27.0 mL
of double distilled water and stirred at 14,000 rpm for 15 s (Heidolph,
silence crasher, Germany). After evaporation of ethanol by rotary vac-
uum at 408C water bath, a freeze dryer was used to lyophilize of
remaining fraction. For the preparation of the coarse suspension,
30.0 mg of coenzyme Q10 was added in 30.0 mL of cold distilled water
(containing 10% v/v ethanol). The coenzyme Q10 content of both was
adjusted to about 1 mg/mL.
2.3 | Characterization of the prepared CoQ10-NPs
The particle size distribution and zeta potential of the CoQ10-NPs
were determined by dynamic light scattering (DLS) using a nano/
zetasizer (Malvern Instruments, Worcestershire, UK, model Nano ZS) at
room temperature. The synthesized nanoparticles were characterized
for their size and structure by transmission electron microscopy (Zeiss,
Germany). The samples stained with 0.5% (w/v) phosphotungstic acid
on copper grids for observation before TEM analysis.
2.4 | Animal treatment
Adult Male Wistar rats (body weight 280–320 g) were kept in standard
laboratory conditions with a 12-h light/dark cycle by the animal
research center of Tabriz University of Medical Science, Tabriz, Iran.
The animals received humane care according to the ethical guidelines
of the National Institute of Health (NIH publication No. 85-23, revised
1985) and guidelines of Tabriz University of Medical Sciences,
approved by a Committee of Animal Experimentation (No: 91/2-2/5/4
Dec 2012).
2.5 | Isolation and incubation of rat hepatocytes
Rat hepatocytes were isolated with collagenase-perfusion method fol-
lowing the exclusion of calcium ions (Ca21) with a chelator (EGTA
0.5 mM) as described previously.19 The isolated hepatocytes in a den-
sity of 106/mL were then suspended in the Krebs-Henseleit buffer
(pH57.4) in continuously rotating round bottom flasks supplemented
with 12.5mM HEPES, in a 378C water bath under an atmosphere of
carbogen gas (95% O2 and 5% CO2).
20,21 Hepatocytes were preincu-
bated for 30 min prior to addition of chemicals to adopt the medium.
Freshly prepared chemical stock solutions (100 3 concentrated for the
water solutions or 1000 3 concentrated for the methanolic solutions)
were utilized in this experiment. To avoid either nontoxic or very toxic
circumstances, we used LC50 concentrations (1mM) for DDVP.
2.6 | Cell viability
Hepatocyte viability was evaluated microscopically by trypan blue
(0.1%, w/v) exclusion test [17]. Sampling was performed every 60 min
during a 3h of incubation period while 85–90% of hepatocytes were
viable before use
2.7 | Reactive oxygen species (ROS) formation assay
To assess the amount of hepatocyte ROS generation after DDVP was
added to 2.7-dichlorofluorescein diacetate (DCFH-DA) containing
hepatocytes to hepatocytes as it infiltrates hepatocytes and is hydro-
lyzed to non-fluorescent dichlorofluorescein (DCF) by an intracellular
esterase. DCFH then reacts with reactive species and changes into
highly fluorescent dichlorofluorescin. In 1, 2 and 3 h time points over
isolation, 1 mL (106 cell) of hepatocytes suspension was picked up and
centrifuged at 3000g for 1 min. Fluorescence intensity per 106 cells as
a result of ROS production was measured using a Jasco R_FP-750
spectrofluorometric (Jasco Corporation, Tokyo, Japan) with excitation
and emission wavelengths of 500 and 520 nm, respectively.22
2.8 | Determination of lipid peroxidation
Lipid peroxidation (LPO) of the hepatocytes was determined through
measuring thiobarbituric acid reactive substances (TBARS).23 Briefly,
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1 mL of hepatocytes suspension (106 cells/mL) was treated with 250
lL trichloroacetic acid (TCA 70% w/v) and centrifuged at 3000g for
15min; then 1mL of thiobarbituric acid (TBA 0.8% w/v) was added to
supernatant while boiling for 20 min. The absorbance was determined
at 532 nm in an Ultrospec® 2000 UV spectrophotometer.24,25
2.9 | Mitochondrial membrane potential (MMP) assays
The cationic dye, rhodamine 123 accumulates in intact mitochondria.
When MMP is altered by any xenobiotic, the facilitated diffusion of
dye is diminished leading to the elevation of the amount of rhodamine
123 in media. At the given times, aliquots of 1 mL samples of the cell
suspension were taken and centrifuged at 1000 g for 1 min. Then, the
cell pellet was resuspended in 2 mL of fresh incubation medium con-
taining 1.5 lM of rhodamine 123 and incubated at 378C in a water
bath with a gentle shaking. Hepatocytes were separated by centrifuga-
tion at 3000 g for 1 min and the amount of rhodamine 123 remaining
in the incubation medium was calculated using a Jasco FP-750
fluorescence spectrophotometer set at 490 nm excitation and 520 nm
emission wavelengths.26,27
2.10 | Lysosomal membrane integrity assay
Acridine orange redistribution was utilized to assess the hepatocyte
lysosomal membrane stability.28 In brief, 0.5 mL of the prestained cell
suspension with acridine orange (5 mM) was picked up from the incuba-
tion medium and was centrifuged 1 min at 800 g. Afterwards, the cell
pellet was resuspended in 2 mL of fresh incubation buffer. In order to
remove the florescent dye from the media, a two time washing process
was performed. The distribution of dye in the cell suspension was then
assessed fluorimetrically using a Jasco FP-750 fluorescence
spectrophotometer set at 495 nm excitation and 530 nm emission
wavelengths.
2.11 | Measurement of intracellular GSH and GSSG
Reduced glutathione (GSH) and glutathione disulfide (GSSG) in isolated
hepatocytes was measured in deproteinized samples (5% metaphos-
phoric acid) after derivatization with iodoacetic acid and1-fluoro-2,4-
dinitrobenzene,29 using a mBondapak NH2 column, by HPLC (Water
Associates, Milford, MA).
To do the experiment, the reaction of S-carboxymethyl derivatives
of free thiols with iodoacetic acid was followed by conversion of free
amino groups to 2, 4-dinitrophenyl derivatives through reaction with
FDNB. Briefly, 0.8 mL of the cell suspension was spun at 50 g for 40 s,
and the cell pellet was resuspended in 0.8 mL of fresh Krebs-Hensleit
medium. Deproteinization of the cell suspension was performed with
the addition of 0.2 mL volume of 25% metaphosphoric acid with a fur-
ther centrifugation at 100g for 5 min. In the presence of excess sodium
bicarbonate, the mixture of 0.5 mL of supernatant and 0.05 mL of iodo-
acetic acid was sealed and left in the dark and room temperature for
1 h. Eventually, 0.5 mL of FDNB solution (1.5%, v/v in ethanol) was
added to the sample, left in the dark for 24 h at room temperature and
then was examined by HPLC.
2.12 | In vivo studies
The animals were divided into following five groups (5 animals in each
group) for 30 days: Group 1 (control): vehicle (0.9% saline solution) via
oral gavage. Group 2: DDVP-treated animals (1.6 mg/kg body weight)
(1/50 LD oral dose) per day. Group 3: NAC (100 mg/kg body weight
per day)301DDVP (1.6 mg/kg body weight per day) via oral gavage.
Group 4: CoQ10 (50 mg/kg body weight per day)311DDVP (1.6 mg/
kg body weight per day) via oral gavage. Group 5: CoQ10-NPs (50 mg/
kg body weight per day)1DDVP (1.6 mg/kg body weight per day) via
oral gavage. Antioxidants intake was done 3 h prior to DDVP-
administration. After the completion of treatment, all animals were
fasted for 12 h, then blood was sampled via the abdominal vena cava
using pentobarbital anesthesia. Serum alanine transaminase (ALT),
aspartate aminotransferase (AST) and gamma-glutamyl transpeptidase
(GGT) activities were measured with a commercial kit. To assess the
histopathological changes, paraffin-embedded liver sections were
stained with heamotoxyline and eosine (H&E) before light microscopy.
The livers were removed, rinsed in ice-cold physiological saline (0.9%
NaCl) and homogenized using a Teflon homogenizer (Heidolph Silent
Crusher M). The liver homogenate was centrifuged at 1600 g for 15 min
at 48C to prepare supernatants. Malondialdehyde (MDA) concentration in
tissues was considered as nmol MDA per milligram of protein of liver tis-
sue. Catalase (CAT) and superoxide dismutase (SOD) activities were
measured according to the methods described by Aebi and Beauchamp
respectively.32,33 Total glutathione peroxidase (GPx) was measured as
unit/mg protein according to the method of Flohe et al.34 The protein
concentration was asssed by the method of Lowry et al.35
2.13 | Statistical analysis
Data are presented as the Mean6 SD for at three independent
experiments. Results were statistically analyzed by one-way analysis of
variance (ANOVA) followed by Tukey’s post hoc test to assess signifi-
cance. Results with values for P < .05 were taken as statistically
significant.
3 | RESULTS
3.1 | Particle size analysis and morphological
characterization
As shown in DLS plot, it is evident that prepared NPs have a narrow
size distribution and are highly monodispersed (Figure 1A). Moreover,
the CoQ10-NPs displayed an effective diameter of 54 nm, while zeta
potential was found to be 224 mV (Figure 1A). Additionally, TEM
micrograph shows that CoQ10-NPs are morphologically spherical and
uniform in size distributions, which was confirmed the results of DLS
analysis (Figure 1B). As presented in Figure 2, the appearances of
coarse suspensions and the CoQ10-NPs were different. It was found
that all nanocrystals were homodispersed; on the contrary, the bulk
CoQ10 dispersed in suspension was quite unstable after 2 days, while
the 54 nm-sized nanocrystals were physically stable for during 3 month
at room temperature.
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3.2 | Cytotoxicity caused by DDVP
1mM of DDVP showed 50% cell death (LC50) in a dose depended
manner as determined by the trypan blue exclusion test in 120 min of
incubation (data not shown). 1mM as LC50 was applied to investigate
mechanisms of cytotoxicity and alterations in biochemical markers. In
comparison with control hepatocytes, 1mM of DDVP increased hepa-
tocyte membrane lysis significantly (Figure 3). 300 mM of CoQ10 and
200 mM of NAC effectively reduced DDVP-induced cell death (Figure
3). The same concentration (300 mM) of CoQ10-NPs and CoQ10 was
used in order to compare the protective effects of these agents. As
presented in Figure 4, DDVP-induced toxicity in CoQ10-NPs treated
hepatocytes were significantly reduced in comparison to the CoQ10
treated hepatocytes.
3.3 | ROS formation and lipid peroxidation
As shown in Figure 4, incubation of hepatocytes with DDVP caused
significant increase in dichlorofluorescein (DCF) fluorescence in
comparison to normal cells. Also, DDVP toxicity was associated with
the peroxidation of membrane lipids (Figure 5). Treatment with antioxi-
dants (NAC and CoQ10) protected hepatocytes against DDVP-induced
ROS formation and LPO (Figures 4 and 5). Moreover, CoQ10 nanopar-
ticles substantially decreased the ROS and LPO levels in comparison
with free CoQ10 (P < .05) (Figures 5 and 6).
3.4 | The effects of DDVP on mitochondrial
membrane potential
Measuring of fluorescent probe rhodamine 123 as main indicator of
mitochondrial membrane potential examines the role of ROS formation
in mitochondrial damage. Administration of CoQ10 and NAC signifi-
cantly decreased the DDVP (1mM) induced mitochondrial membrane
potential collapse (Figure 6). Also, nanoparticles of CoQ10 significantly
reduced MMP alteration in comparison to nonparticulate form of
CoQ10 (P < .05) (Figure 6).
3.5 | DDVP-induced lysosomal membrane damage
Incubation of acridine orange (a lysosomotropic agent) loaded hepato-
cyte with DDVP, resulted in a significant release of the fluorescent dye
into the cytosolic fraction within 1 h representing a lysosomal mem-
brane damage (Figure 7). DDVP-induced acridine orange redistribution
was again prevented by NAC, CoQ10 and CoQ10-NPs (Figure 7).
CoQ10-NPs treated group exhibited a significant reduction in the lyso-
somal leakiness in comparison with CoQ10 treated group (Figure 7). All
of these compounds did not show any marked effects effect (P < .05)
on acridine orange redistribution from lysosomes to cytosol in normal
cells.
3.6 | The effects of DDVP on GSH/GSSG levels
Incubation of hepatocytes with DDVP (1mM) potentiate glutathione
depletion of GSH which was significantly prevented by CoQ10 and
NAC (P < .05) (Table 1).Interestingly, administration of CoQ10-NPs
reduces the glutathione reduction profoundly more than free CoQ10 in
isolated hepatocytes (Table 1). All these findings indicate the occur-
rence of oxidative stress after DDVP administration in isolated rat.
FIGURE 1 Dynamic light scattering (DLS) of the CoQ10-NPs (A). TEM image of Coenzyme Q10 nanoparticles. The average size of CoQ10-
NPs was 54 (B) [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 2 Suspensions of bulk drugs and coenzyme Q10
nanocrystals after storage for 2 days at room temperature. Note:
From left to right: CoQ10 nanocrystals and free CoQ10
respectively. The CoQ10 content of two formulations was about
1 mg/mL. [Color figure can be viewed at wileyonlinelibrary.com]
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3.7 | In vivo results
ALT, AST and GGT as main markers of liver function in different treated
groups are presented in Table 2. DDVP administration increased the lev-
els of AST, ALT, and GGT to higher extend when compare to the control
group (P < .05). In contrast pretreatment of rats with NAC, CoQ10 and
CoQ10-NPs significantly reduced the above-mentioned alterations (P <
.05). Moreover, AST, ALT and GGT levels were significantly lower in of
CoQ10-NPs (P < .05) (Table 2). The histopathological results showed
that DDVP administration causes hepatocyte degeneration, fatty
changes and inflammatory cell infiltration which was significantly
improved after CoQ10 and also CoQ10-NPs. However, this effect was
in a greater extent in CoQ10-NP treated group (Figure 8).
As shown in Table 3, DDVP-intoxication significantly plummeted
the activity of the SOD, CAT, and GPx enzymes compared with the nor-
mal control (P < .05). While, pretreatment of rats with NAC, CoQ10 and
CoQ10-NPs significantly improved liver antioxidant content (P < .05).
Also, the result of this study showed that particulated CoQ10 had a
more beneficial effect in antioxidant activity of DDVP-intoxicated livers.
4 | DISCUSSION
Nano antioxidants like CoQ10 nanoparticles are safe, biocompatible,
and biodegradable with no toxicity and possessing intrinsic antioxidant
properties in attenuating of free radical induced oxidative damage.
FIGURE 3 DDVP-induced cell cytotoxicity (1mM) and the effect of antioxidants: CoQ10 (300mM), NAC (200mM) and CoQ10-NPs (300
mM) in isolated rat hepatocytes. *Significantly higher than control hepatocytes (P < .05). a CoQ10 (1 mM) significantly decreased hepatocyte
membrane lysis compared to DDVP treated hepatocytes. **Co10-NPs (1 mM) significantly decreased hepatocyte membrane lysis compared
to DDVP- and CoQ10-treated hepatocytes. Data are shown as mean6 SD for at least three different experiments. [Color figure can be
viewed at wileyonlinelibrary.com]
FIGURE 4 Reactive oxygen species formation induced by DDVP and the protective effects of CoQ10, CoQ10-NPS and NAC. Isolated rat
hepatocytes (106 cells/mL) were incubated at 378C in rotating round bottom flasks with 95% O2 and 5% CO2 in Krebs-Henseleit buffer (pH
7.4). *Different from control group (P < .05). aSignificantly different from DDVP-treated hepatocytes(P < .05). a,bSignificantly different from
DDVP and CoQ10 treated cells (P < .05). Data are shown as mean6SD for at least three different experiments. [Color figure can be
viewed at wileyonlinelibrary.com]
AZIZ EFTEKHARI ET AL. | 5
Among several chemical techniques for the synthesis of nanopar-
ticles, precipitation method is a simple and quick preparative method
and also size-controllable approach. The precipitation process offers
advantages like simplicity, low cost, high purity of product and not
requiring organic solvents 36. In this study, we used the nanoprecipita-
tion technique that possesses numerous benefits, which offers repro-
ducible particle size with a narrow distribution (PDI value of 0.18) and
is comparatively straightforward and rapid.
Preparing reproducible particle size and being a rapid technique
makes nanoprecipitation a favorite method to produce nanomaterials
and we also used in this experiment.37–39 The smaller nanoparticles are
made, the larger surface area is provided leading to enhanced efficacy
and increased agent bioavailability. Besides, it appears that original
physicochemical properties are boosted with nanoparticulation, provid-
ing the crystalline structure which might alter the release profile of
nonparticulate CoQ10.
The intensity-weighted mean diameter of the bulk population
is measured with DLS method or photon correlation spectroscopy
(PCS). As presented in Figure 1A, the diameter for CoQ10-NPs
was calculated to be 54 and the prepared CoQ10-NPs had a
narrow size distribution with a spherical and uniform morphology
(Figure 1B).
FIGURE 5 TBARS formation induced by DDVP and the protective effects of CoQ10, CoQ10-NPS and NAC. Isolated rat hepatocytes (106
cells/mL) were incubated at 378C in rotating round bottom flasks with 95% O2 and 5% CO2 in Krebs–Henseleit buffer (pH 7.4). *Different
from control group (P<0.05). aSignificantly different from DDVP-treated hepatocytes(P<0.05). a,bSignificantly different from DDVP and
CoQ10 treated cells (P<0.05). Data are shown as mean6 SD for at least three different experiments. [Color figure can be viewed at
wileyonlinelibrary.com]
FIGURE 6 Mitochondrial depolarization induced by DDVP and the protective effects of CoQ10, CoQ10-NPS and NAC. Isolated rat hepa-
tocytes (106 cells/mL) were incubated at 378C in rotating round bottom flasks with 95% O2 and 5% CO2 in Krebs–Henseleit buffer (pH
7.4). *Different from control group (P < .05). aSignificantly different from DDVP-treated hepatocytes(P < .05). a,bSignificantly different from
DDVP and CoQ10 treated cells (P < .05). Data are shown as mean6SD for at least three different experiments. [Color figure can be
viewed at wileyonlinelibrary.com]
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To underline the hepatoprotective role of CoQ10 and its particu-
lated form in liver damage, we utilized the accelerated cytotoxicity
mechanism screening (ACMS) technique. In this method a high drug
dose over 3 h exhibitions similar hepatotoxic effect in vitro as would do
a lower drug dose over a longer period of time (24–48 h) in vivo,40
which makes it useful to predict and characterize liver toxicity in vivo.
The superiority of CoQ10-NPs could be explained in this way that
nanoparticle systems have a better aqueous solubility profile and a
smaller size, so a higher concentration of the bioactive compound could
be delivered into the cell compartment. Besides, due to the small size
of CoQ10-NP, it is easily transported across hepatic sinusoid. While,
elevated aqueous solubility renders the nanoparticle the superiority to
provide a higher concentration in damaged liver tissue to better prohi-
bition of the caspase signaling cascade to prevent hepatocyte cell
death.
Mitochondria as cellular powerhouses are known to be the major
energy sources and any damage to these organelles leads to the disrup-
tion of ATP producing cascades. Furthermore, constant leakage of elec-
trons in the respiratory chain, turns mitochondria into a chief oxidative
stress target in most mammalian cells.41 The present study demon-
strated that the hepatocyte MMP was declined by DDVP which in turn
led to the mitochondrial permeability transition pore (MPTP). Further-
more, delay in MMP collapse with antioxidants (NAC, CoQ10, CoQ10-
NPs) proposed that MMP collapse was a consequence of ROS forma-
tion which is in accordance with published reports.42,43 Also, improved
function of CoQ10-NPs in comparison with bare CoQ10 suggested the
accumulation of sufficient concentration of CoQ10 juxta mitochondria.
Moreover, enhanced penetration of CoQ-NPs into the mitochondrial
membrane is another hypothesis which need further experiments to be
proved completely.
FIGURE 7 Lysosomal membrane damage induced by DDVP and the protective effects of CoQ10, CoQ10-NPS and NAC. Hepatocytes (106
cells/mL) were incubated in Krebs–Henseleit buffer pH 7.4 at 378C for 3.0 h following the addition of DDVP (1 mM). Lysosomal membrane
fragility was measured as fluorescent intensity unit of diffused cytosolic green fluorescence induced by acridine orange following the redis-
tribution from lysosomes into cytosol in acridine-orange-loaded hepatocytes. *Different from control group (P < .05). aSignificantly different
from DDVP-treated hepatocytes(P < .05). a,bSignificantly different from DDVP and CoQ10 treated cells (P < .05). Data are shown as
mean6SD for at least three different experiments. [Color figure can be viewed at wileyonlinelibrary.com]
TABLE 1 Effect of antioxidants on Intracellular GSH and GSSG during DDVP-induced hepatocyte damage
Addition Intracellular GSH (nmol/10
6 cell) Intracellular GSSG (nmol/106 cell)
Incubation Time 60 120 180 60 120 180
Control 57.46 3.2 52.26 2.8 49.16 4.2 5.16 2.5 6.965.2 10.16 6.4
DDVP(1mM) 40.76 5.4* 38.86 6.1* 34.76 3.4* 10.46 6.2* 14.965.4* 19.26 4.8*
DDVP (1mM)1CoQ10(300mM) 50.66 2.2a 46.86 3.5a 42.46 4.6a 7.06 3.3a 8.566.7a 11.86 4.6a
DDVP(1mM) 1
CoQ10-NPs(300mM)
56.26 4.3a,b 51.96 2.3a,b 49.26 5.9a,b 5.26 5.2a,b 6.964.4a,b 9.86 3.9a,b
DDVP(1mM)1NAC(200mM) 51.26 6.4a 49.66 3.4a 46.16 3.8a 7.46 2.9a 8.364.3a 10.86 5.8a
Hepatocytes (106 cells/mL) were incubated in Krebs–Henseleit buffer pH 7.4 at 378C for 3.0 h following the addition of DDVP (1 mM). Intracellular
GSH and GSSG was determined by HPLC analysis 45. *Different from control group (P < .05). aSignificantly different from DDVP-treated hepatocytes
(P < .05). a,bSignificantly different from DDVP and CoQ10 treated cells (P < .05). Values shown are the means6 SD of three separate experiments.
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DDVP administration has been shown to induce oxidative stress
which is concomitant with decreased glutathione reductase, reduced
and oxidized glutathione levels in different tissues.2 In the current
study, we observed a substantial GSH deprivation, which might be a
mechanism for the DDVP-induced toxicity in isolated rat hepatocytes.
Our results showed that antioxidants (NAC and CoQ10) are able to
increase hepatocytes glutathione levels and this effect may also con-
tribute to protection against DDVP-induced cytotoxicity. Also, for the
first time, this study demonstrated that potential antioxidant effect of
nano-CoQ10 was considerably higher than CoQ10 in replenishment of
GSH pools in DDVP-exposed isolated rat hepatocytes.
High amounts of intracellular lipophilic H2O2 are generated subse-
quent to the ROS formation in the mitochondria, which in turn diffuse
easily in the cell and pass lysosomal membrane due to the inadequate
detoxifying processes where in a Fenton type reaction with lysosomal
Fe31, highly reactive hydroxyl radicals are produced leading to the LPO
of membrane and lysosomal membrane leakiness. Defects in lysosomal
membrane integrity result in the liberation of lysosomal digestive pro-
teases into the cytosol. This toxic pathway triggers the oxidative cycle
from mitochondria to lysosomes.
The protective effects of CoQ10 in lysosomal membrane integrity
of isolated rat hepatocytes offer evidence that CoQ10 was found to
contribute to both as a single-electron transporter and also a proton
carrier in lysosomes similar to what happens in the respiratory chain of
mitochondria. The reduction-oxidation of CoQ10 in lysosomal mem-
brane boosts this organelle to enhanced cleaning of the cellular derbies.
Inhibition of DDVP-induced ROS production, MMP loss and lysosomal
membrane damage by CoQ10, NAC and nano-CoQ10 shows the coun-
ter action of aforementioned agents on lysosomal, mitochondrial outer
membrane permeability and all subsequent stages of the apoptotic cas-
cade which is in line with previous investigations. These relevant out-
comes recommend that there is a close-fitting link between
mitochondria and lysosomes which possibly take part in DDVP-
induced toxicity.
TABLE 2 Hepatoprotective effect of the CoQ10 and its nanopar-
ticles on liver function markers in rats with DDVP-induced
hepatotoxicity
Treatment AST (U/L) ALT (U/L) GGT (U/L)
Control 54.16 3.2 40.664.8 2.76 0.1
DDVP 96.56 3.8a 89.165.1a 10.46 2.1a
NAC1DDVP 83.46 2.2b 74.663.3b 6.76 1.6b
CoQ101DDVP 81.36 4.2b 72.365.4b 7.26 2.3b
CoQ10-NPs1DDVP 59.36 5.6b,c 54.566.2b,c 3.56 0.8b,c
DDVP: dichlorvos; NAC: n-acetylcysteine; CoQ10: Coenzyme Q10;
CoQ10-NPs: Coenzyme Q10 nanoparticles; AST: aspartate
aminotransferase; ALT: alanine aminotransferase; GGT: gamma glutamyl
transferase;.
Values are mean6 SD for five animals in each observation.
aSignificantly different from control group (P < .05).
bSignificantly different from DDVP- intoxicated group (P < .05).
cSignificantly different from DDVP groups treated with CoQ10 (P < .05).
FIGURE 8 Histopathological damage induced by DDVP (B) and the protective effects of CoQ10 (C) and CoQ10-NPS (D). DDVP adminis-
tration resulted in hepatocyte degeneration, fatty change (white arrows) and inflammatory cell infiltration (Black arrows) in comparison with
control group (A). [Color figure can be viewed at wileyonlinelibrary.com]
8 | AZIZ EFTEKHARI ET AL.
Our in vivo studies showed that DDVP induced hepatotoxicity in
rats, which were associated by the increment of liver function enzymes
and decrease in the activity of antioxidant enzymes.
Regarding our in vivo work, DDVP has a significant effect in miti-
gation of liver antioxidant enzyme levels.
H2O2 is produced via the function of SOD followed by induction
of hydroxyl radicals throughout Fenton and/or Haber–Weiss reactions
if the agent is not removed by CAT and/or GSH.44 Exposure to organo-
phosphate pesticides is often followed by impairment of the antioxi-
dant defense and characterized by the depletion of GSH. In the current
study, we showed that NAC, CoQ10 and its nanoparticles counterpart
played detoxifying roles in metabolizing the xenobiotics through
enhancement of SOD, CAT, and GPx levels to scavenge the ROS
radicals and MDA levels generated from DDVP. Furthermore, our data
also proposed that pretreatment with NAC, CoQ10 and CoQ10-NPs
effectively reduced the leakage of AST, ALT and GGT and prevented
the DDVP-intoxication-mediated progression of hepatotoxicity
which were also apparent in the histopathological results. The
effects of CoQ10-NPs in DDVP-induced liver toxicity were summar-
ized in Figure 9.
5 | CONCLUSION
The outcomes of this study revealed the hepatoprotective role of
CoQ10-NPs as well as its enhanced antioxidant effect to improve
TABLE 3 Effect of the NAC, CoQ10 and its nanoparticles on lipid peroxidation and antioxidant enzyme activities from the liver homogenate
of rats with hepatotoxicity induced by DDVP
Treatment
SOD (U/mg
protein)
CAT (K/mg
protein)
GPx (U/mg
protein)
MDA (nmol/mg
protein)
Control 8.360.9 75.263.3 68.363.1 113.46 5.6
DDVP(1.6 mg/kg) 2.560.3a 29.561.6a 22.461.9a 221.66 6.2a
NAC (100 mg/kg)1DDVP 5.060.4 b 45.964.2b 41.163.6b 156.86 3.9 b
CoQ10 (50 mg/kg)1DDVP 4.160.9b 43.563.6b 37.562.6b 162.96 6.2 b
CoQ10-NPs (50 mg/kg) 1DDVP 6.660.8b,c 65.962.5b,c 56.164.3b,c 118.66 4.2b,c
DDVP: dichlorvos; NAC: n-acetylcysteine; CoQ10: Coenzyme Q10; CoQ10-NPs: Coenzyme Q10 nanoparticles; Values were expressed as mean6 SD
for five animals in each observation.
aSignificantly different from control group (P < .05).
bSignificantly different from DDVP-intoxicated group (P < .05).
cSignificant difference in DDVP groups treated with CoQ10 (P < .05).
FIGURE 9 Schematic picture describing in an illustrative and comprehensive way the experimental set-up and the results/outcome. [Color
figure can be viewed at wileyonlinelibrary.com]
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CoQ10 medical application due to its poor absorption and bioavailabil-
ity in oral administration. Many researchers have attempted to increase
the effect CoQ10 on mitochondrial transport chain to combat drug
and/or toxin-induced mitopathy and to reduce ROS production in
recent years. In this regard, mitigation of hepatotoxicity caused by
DDVP in which oxidative stress and mitochondrial malfunction
are shown to be the major mechanisms of toxicity was studied and
treatment of hepatocytes with CoQ10-NPs, CoQ10 and NAC as
putative antioxidants inhibited DDVP-induced toxicity while the nano-
formulated form of CoQ10 presented a more potent impact in neutrali-
zation of DDVP-associated side effects in rat hepatocytes. Hence, the
results of this investigation suggest a new strategy to protect against
organophosphate pesticide toxicity in the liver and maybe other organs.
In summary, CoQ-NPs are deemed to be a safe supplementary thera-
peutics in pathologies related to xenobiotics-induced liver injuries.
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